Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10170
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imaging and laboratory diagnostics; audiology solutions; industrial technologies and automation systems; infrastructure and building technologies; and mobility and logistics solutions. Siemens also offers drive and software solutions, besides business-to-business financial solutions. Its customers include public utilities, independent power producers, oil and gas companies, hospitals and diagnostics centers, transportation companies, network operators, infrastructure developers, and industrial companies. The company has operations across Europe, Commonwealth of Independent States, Africa, the Middle East, Americas, and Asia Pacific. Siemens is headquartered in Munich, Germany.

Siemens AG (SIE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siemens AG, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
ICBio to Raise up to USD2 Million in Private Equity 10
Partnerships 11
Siemens Healthcare Enters into Co-Development Agreement with Biogen 11
Equity Offering 12
Siemens Healthcare Raises USD5.71 Billion in IPO 12
Asset Transactions 14
Beckman Coulter To Acquire Clinical Microbiology Business Of Siemens 14
Siemens AG – Key Competitors 15
Siemens AG – Key Employees 16
Siemens AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 25
Joint Venture 25
Recent Developments 26
Other Significant Developments 26
Aug 22, 2018: Siemens helps bring comfort and efficiency to Louisiana Hospital 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Siemens AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ICBio to Raise up to USD2 Million in Private Equity 10
Siemens Healthcare Enters into Co-Development Agreement with Biogen 11
Siemens Healthcare Raises USD5.71 Billion in IPO 12
Beckman Coulter To Acquire Clinical Microbiology Business Of Siemens 14
Siemens AG, Key Competitors 15
Siemens AG, Key Employees 16
Siemens AG, Subsidiaries 18
Siemens AG, Affiliate 25
Siemens AG, Joint Venture 25

List of Figures
Siemens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Disproquima S.A.:戦略・SWOT・企業財務分析
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • El Pollo Loco Holdings, Inc.:企業の戦略・SWOT・財務情報
    El Pollo Loco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary El Pollo Loco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Venture Life Group Plc (VLG):企業の財務・戦略的SWOT分析
    Summary Venture Life Group Plc (Venture Life) is a consumer goods company that offers ageing population products. The groups product and pipeline comprise food supplements for lowering cholesterol and maintaining brain function, medical devices for improving minor aches and pains, dry eyes and itchy …
  • Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Boustead Heavy Industries Corporation Berhad:戦略・SWOT・企業財務分析
    Boustead Heavy Industries Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Triskalia SCA:企業の戦略・SWOT・財務情報
    Triskalia SCA - Strategy, SWOT and Corporate Finance Report Summary Triskalia SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • ScinoPharm Taiwan Ltd (1789):製薬・医療:M&Aディール及び事業提携情報
    Summary ScinoPharm Taiwan Ltd (ScinoPharm) provides process research and development (R&D) and active pharmaceutical ingredient (API) manufacturing services to the pharmaceutical industry. It services include custom synthesis for early phase pharmaceutical activities, brand companies and APIs for th …
  • Jupiter Telecommunications Co Ltd:企業の戦略的SWOT分析
    Jupiter Telecommunications Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Jagatjit Industries Limited:企業の戦略・SWOT・財務情報
    Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Eversource Energy (ES)-エネルギー分野:企業M&A・提携分析
    Summary Eversource Energy (Eversource) is a utility holding company which operates energy delivery business through its subsidiaries. It transmits and distributes electricity and natural gas. The company sources electricity from its facilities, long-term power supply agreements, and competitive ener …
  • Carmell Therapeutics Corp:製品パイプライン分析
    Summary Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for tot …
  • Ypsomed Holding AG (YPSN)-医療機器分野:企業M&A・提携分析
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, industrial design, human factors engineerin …
  • McGill University-製薬・医療分野:企業M&A・提携分析
    Summary McGill University (McGill) is a research based educational institute. The university offers undergraduate, graduate and post-graduate courses. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, l …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Shin-Etsu Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆